Gerald P. Bodey
- Clinical Biochemistry top 0.01%
- Bacterial Identification and Susceptibility Testing 62
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 107
- Infectious Diseases top 0.05%
- Antifungal resistance and susceptibility 86
- Oncology top 0.05%
- Neutropenia and Cancer Infections 214
- Endocrinology top 0.1%
-
- Antibiotics Pharmacokinetics and Efficacy 95
-
- Fungal Infections and Studies 65
-
- Cancer therapeutics and mechanisms 47
-
- Acute Lymphoblastic Leukemia research 42
- Co-authors
- Issam RaadVictorio RodriguezLinda S. EltingEmil J. FreireichDimitrios P. KontoyiannisVictor FainsteinE. AnaissieKenneth V. I. Rolston
- Journals
- Cancer (83 papers)Antimicrobial Agents and Chemotherapy (78 papers)Clinical Infectious Diseases (37 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Gerald P. Bodey
634 papers receiving 29.1k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Clinical Biochemistry 4.3k
- Molecular Medicine 2.8k
- Infectious Diseases 9.6k
- Oncology 11.9k
- Endocrinology 2.0k
Countries citing papers authored by Gerald P. Bodey
This map shows the geographic impact of Gerald P. Bodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald P. Bodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald P. Bodey more than expected).
Fields of papers citing papers by Gerald P. Bodey
This network shows the impact of papers produced by Gerald P. Bodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald P. Bodey. The network helps show where Gerald P. Bodey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerald P. Bodey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 191 | |
| 2 | The evolution of antibiotic therapy for neutropenic patients. | 1997 | 4 |
| 3 | 1996 | 3 | |
| 4 | Candidiasis : pathogenesis, diagnosis, and treatment | 1993 | 104 |
| 5 | 1992 | 103 | |
| 6 | Human/Computer Interfaces: A Randomized Trial of Data Entry and Editing Formats | 1988 | 1 |
| 7 | Continuous five-day infusion of vindesine in the treatment of metastatic malignant melanoma | 1982 | 1 |
| 8 | Short-term sequential (S-TS) chemotherapy in young patients with acute myelogenous leukemia (AML) | 1981 | 2 |
| 9 | Results of a phase II study of maytansine in patients with breast carcinoma and melanoma. | 1979 | 12 |
| 10 | Chemotherapy for sarcoma of the stomach. | 1979 | 4 |
| 11 | Initial clinical studies of gallium (GA) nitrate (N) NSC 15200 | 1978 | 1 |
| 12 | Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. | 1978 | 63 |
| 13 | In vivo perturbation of human marrow cell cycle progression by ifosfamide. | 1978 | 8 |
| 14 | Sequential chemotherapy in the treatment of cancer of the head and neck | 1977 | 2 |
| 15 | Increased remission rate and prolongation of survival in patients with soft tissue sarcomas treated with intensive chemotherapy on a protected environment prophylactic antibiotic program (PEPA) | 1977 | 6 |
| 16 | A phase I II study of adriamycin DNA complex (A DNA) | 1977 | 2 |
| 17 | Combination chemotherapy (CHOP BLEO) of advanced diffuse histiocytic lymphoma (DHL) | 1976 | 2 |
| 18 | Preliminary clinical evaluation of piperazinedione (P), a new crystalline antibiotic | 1975 | 5 |
| 19 | Protected environments (PE) and prophylactic antibiotics in remission induction therapy of adults with acute leukemia | 1974 | 1 |
| 20 | Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors. | 1973 | 31 |
About Gerald P. Bodey
Gerald P. Bodey is a scholar working on Molecular Medicine, Oncology, Clinical Biochemistry, Endocrinology and Infectious Diseases, having authored 643 papers that have together received 32.2k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (214 papers), Antibiotic Resistance in Bacteria (107 papers), Antibiotics Pharmacokinetics and Efficacy (95 papers), Antifungal resistance and susceptibility (86 papers), Fungal Infections and Studies (65 papers), Bacterial Identification and Susceptibility Testing (62 papers), Cancer therapeutics and mechanisms (47 papers) and Acute Lymphoblastic Leukemia research (42 papers). The work is most often cited by research in Clinical Biochemistry (4.3k citations), Molecular Medicine (2.8k citations), Infectious Diseases (9.6k citations), Oncology (11.9k citations) and Endocrinology (2.0k citations). Gerald P. Bodey has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Issam Raad, Victorio Rodriguez, Linda S. Elting, Emil J. Freireich, Dimitrios P. Kontoyiannis, Victor Fainstein, E. Anaissie, Kenneth V. I. Rolston, Manuel Valdivieso and Michael J. Keating. Their work appears in journals such as Cancer, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.